THYROXINE (T4) - ANVISA Registration 80022230294
Access comprehensive regulatory information for THYROXINE (T4) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80022230294 and manufactured by GOLD ANALISA DIAGNOSTICA LTDA. The registration is held by GOLD ANALISA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ORTHO-CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80022230294
25351050938202588
03142794000116
Company Information
Dates and Status
May 05, 2025
VIGENTE
09/18/2025 19:00:01
ROCHE DIAGNOSTICS GMBHโข Germany
ORTHO-CLINICAL DIAGNOSTICSโข United Kingdom
ABBOTT IRELAND DIAGNOSTICS DIVISIONโข Ireland
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.โข China
BECKMAN COULTER, INC.โข United States of America
TIROXINA (T4)
Famรญlia MAGLUMI Total T4 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513518
Sep 15, 2025
TIROXINA (T4)
T4 FIA Analyzer Test
GUANGZHOU BIOSURPASS BIOTECHNOLOGY CO., LTD
82102680002
Sep 15, 2025
TIROXINA (T4)
T4 (Imunofluorescรชncia)
ZYBIO INC.
82533950116
Sep 08, 2025
TIROXINA (T4)
SMART TT4
XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
80074330036
Apr 28, 2025
TIROXINA (T4)
Total T4 Chemiluminescent Immunoassay Kit
MACCURA BIOTECHNOLOGY CO LTD
82444370237
Apr 28, 2025

